Phasecraft, a London-based quantum computing startup, has raised $34 million (~€31.5M) in Series B funding to accelerate development of algorithms that make noisy quantum computers useful for real-world problems.
Phasecraft, a London-based quantum computing startup, has raised $34 million (~€31.5M) in Series B funding to accelerate development of algorithms that make noisy quantum computers useful for real-world problems.
Netomnia, the UK’s second-largest alternative network provider, has raised £300M (~€346M) in junior debt funding to expand its nationwide fibre rollout.
Artificial Societies, a London-based AI simulation platform, has raised $5.3 million (~€4.5M) across pre-seed and seed rounds to expand its technology that lets companies test ideas with digital personas before taking them to market.
Bristol-based biotech startup EnsiliTech has raised £4.5 million in seed funding to scale its patented Ensilication® technology, which stabilises vaccines and biologics without refrigeration, even at temperatures up to 50°C.
Paragraf, a UK-based developer of graphene-based electronic devices, has raised $55 million (~€46.9 million) in a Series C round to expand manufacturing capacity and bring its technology into mass-market applications.
Innerworks, a London-based cybersecurity startup, has raised $4M (~€3.4M) in seed funding to expand its fight against AI-powered fraud, bots, and sanctioned actors.
Bumper, the Sheffield and London-based BNPL provider for car repairs, has raised an additional £8M (~€9.3M) in a Series B extension, bringing its total Series B funding to over €57M.
Pulse Clean Energy, a UK-based developer of flexible energy infrastructure, has secured £220 million (approx. €252.5 million) in green debt financing to construct six new battery energy storage system (BESS) sites across England and Wales.
Hytro, a London-based startup pioneering wearable Blood Flow Restriction (BFR) technology, has raised €2.3 million (approx. £2M) in a round backed by athlete-led syndicates Joyned Capital and Skin In The Game.
Ultromics, the Oxford-based AI healthtech company, has raised $55 million in Series C funding to accelerate deployment of its FDA-cleared platform for early heart failure detection.
